Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gene predicts renal problems after heart surgery:

This article was originally published in Clinica

Executive Summary

A gene implicated in Alzheimer's disease may indicate which patients undergoing heart surgery are most likely to suffer post-operative kidney dysfunction, according to a study in the August issue of Anesthesiology. A team from Duke University Medical Center in Durham, North Carolina, found that patients with the E-4 variant of the apolipoprotein (APO) gene were less likely to suffer renal complications than those with either of two other variants. Study leader Dr Mark Stafford-Smith says that the APOE-4 status of patients undergoing this type of surgery should be taken into consideration given the apparent higher risks for subsequent kidney complications.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076782

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel